LBF16000PG01
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1421 |
LipidMaps | LMFA03010136 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF16000PG01 |
8- [2 (R) -(2-Carboxyethyl)-5 (R) -hydroxy-3-oxocyclopentan-1 (R) -yl]-6-oxooctanoic acid | |
---|---|
Structural Information | |
8- [2-(R) -(2-Carboxyethyl)-5-(R) -hydroxy-3-oxocyclopentan-1-(R) -yl]-6-oxooctanoic acid | |
| |
PGE-MUM | |
Formula | C16H24O7 |
Exact Mass | 328.152203122 |
Average Mass | 328.35756000000003 |
SMILES | OC(=O)CCCCC(=O)CC[C@@H]([C@H](O)1)[C@@H](CCC(O)=O)C(=O)C1 |
Physicochemical Information | |
ETHYL ACETATE HambergMet al. | |
When prostaglandin E2 or E1 was administered intravenously to man, 7 alpha -hydroxy-5,11-diketo-tetranor-prosta-1,16-dioic acid was found as a major urinary metabolite (PGE-MUM) Hamberg_M et al.. | |
Spectral Information | |
Mass Spectra | DIMETHYL ESTER DI-O-METHYLOXIME TMS ETHER DERIVATIVE ; m/e 486, 455, 369, 365, 355, 286, 279, 268, 265, 196, 115 HambergMet al. |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|